CA2561293C - Traitement de l'incontinence - Google Patents

Traitement de l'incontinence Download PDF

Info

Publication number
CA2561293C
CA2561293C CA002561293A CA2561293A CA2561293C CA 2561293 C CA2561293 C CA 2561293C CA 002561293 A CA002561293 A CA 002561293A CA 2561293 A CA2561293 A CA 2561293A CA 2561293 C CA2561293 C CA 2561293C
Authority
CA
Canada
Prior art keywords
propanamine
incontinence
methyl
bladder
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002561293A
Other languages
English (en)
Other versions
CA2561293A1 (fr
Inventor
Karl Bruce Thor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority claimed from CA002136120A external-priority patent/CA2136120C/fr
Publication of CA2561293A1 publication Critical patent/CA2561293A1/fr
Application granted granted Critical
Publication of CA2561293C publication Critical patent/CA2561293C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002561293A 1993-11-24 1994-11-18 Traitement de l'incontinence Expired - Lifetime CA2561293C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15812193A 1993-11-24 1993-11-24
US08/158,121 1993-11-24
CA002136120A CA2136120C (fr) 1993-11-24 1994-11-18 Traitement de l'incontinence

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002136120A Division CA2136120C (fr) 1993-11-24 1994-11-18 Traitement de l'incontinence

Publications (2)

Publication Number Publication Date
CA2561293A1 CA2561293A1 (fr) 1995-05-25
CA2561293C true CA2561293C (fr) 2008-03-18

Family

ID=37451524

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002561293A Expired - Lifetime CA2561293C (fr) 1993-11-24 1994-11-18 Traitement de l'incontinence

Country Status (1)

Country Link
CA (1) CA2561293C (fr)

Also Published As

Publication number Publication date
CA2561293A1 (fr) 1995-05-25

Similar Documents

Publication Publication Date Title
CA2136120C (fr) Traitement de l'incontinence
RS20050392A (sr) Farmaceutski preparat sa beta-3- adrenoceptor-agonistom i reuptake-inhibitorom serotonina i/ili norepinefrina
DE69428325T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
RU2395504C2 (ru) Альфа-аминоамидные производные, используемые для лечения расстройств нижних мочевыводящих путей
JP5680412B2 (ja) レオヌリンの使用およびその組成物
KR20040030788A (ko) 요실금 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체
CA2442410A1 (fr) Duloxetine pour le traitement de la bouffee de chaleur
JPH07196492A (ja) 体重増加を抑制する、または体重減少を誘発するための医薬組成物
CA2561293C (fr) Traitement de l'incontinence
HK1013799B (en) Use of venlafaxine or of an aryloxy propanamine compound for the manufacture of a medicament for the treatment of urinary incontinence
GB2291592A (en) Pharmaceutical compositions comprising a bicycloheptane derivative
TW201350118A (zh) 應力性尿失禁預防劑及／或治療劑
JPWO2005007191A1 (ja) 医薬組成物
KR101052804B1 (ko) 과활동방광을 치료하기 위한 페녹시아세트산 유도체의 사용
JP2000503991A (ja) 括約筋受容能力を増大させる方法
Petersen Management of urinary incontinence in children with myelomeningocele
JPH0653679B2 (ja) 尿道内圧増強剤
CZ290573B6 (cs) Léčivo pro oąetřování inkontinence
WO2004045606A1 (fr) Traitement des troubles gastro-intestinaux par administration de duloxetine
MXPA01007833A (es) Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.
KR19990082056A (ko) 괄약근 반응력 증가 방법
MXPA06008188A (en) Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141118